FDx Advisors’s Amsurg Corp AMSG Stock Holding History

FDx Advisors’s Portfolio AMSG Stock Details AMSG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-18,066	Closed	-$1.21M	–	1175
2016 Q3	$1.21M	Buy	18,066 +4,700	+35%	+$328K	0.05%	332
2016 Q2	$1.04M	Sell	13,366 -64	-0.5%	-$4.95K	0.05%	346
2016 Q1	$1M	Buy	13,430 +885	+7%	+$62.3K	0.05%	362
2015 Q4	$953K	Sell	12,545 -783	-6%	-$62K	0.04%	360
2015 Q3	$1.04M	Buy	+13,328	New	+$1.03M	0.09%	234
2015 Q1	–	Sell	-7,085	Closed	-$388K	–	1964
2014 Q4	$388K	Buy	7,085 +1,507	+27%	+$76.8K	0.02%	638
2014 Q3	$279K	Buy	+5,578	New	+$278K	0.02%	810

Other funds holding AMSG

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

FIM

Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

GRP

Global Retirement Partners San Rafael, California $5.64B AUM

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

FDx Advisors's AMSG Position: Q4 2016 in Review

FDx Advisors sold out of Amsurg Corp (AMSG) in Q4 2016, closing a stake of 18,066 shares — an estimated $1.21M sold.

FDx Advisors first reported a position in AMSG in Q3 2014 and held it in 7 quarters. The position peaked at $1.21M in Q3 2016. 7 funds tracked by Wall St. Rank hold AMSG as of Q4 2016.

FDx Advisors reported no remaining Amsurg Corp position as of Q4 2016 after selling out during the quarter.
FDx Advisors sold 18,066 Amsurg Corp shares in Q4 2016, an estimated $1.21M.
FDx Advisors first reported a position in Amsurg Corp in Q3 2014 and held it in 7 quarters.
FDx Advisors's Amsurg Corp position peaked at $1.21M in Q3 2016.
7 funds tracked by Wall St. Rank held Amsurg Corp as of Q4 2016.

Based on FDx Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.